ALS Treatment Extension Study

Clinical trial NCT03136809 · UNKNOWN

Trial details

NCT number: NCT03136809
Sponsor: Collaborative Medicinal Development Pty Limited
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2018-01-18
Primary completion: 2022-12-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.